308 related articles for article (PubMed ID: 15966738)
1. The loop C region of the murine 5-HT3A receptor contributes to the differential actions of 5-hydroxytryptamine and m-chlorophenylbiguanide.
Suryanarayanan A; Joshi PR; Bikádi Z; Mani M; Kulkarni TR; Gaines C; Schulte MK
Biochemistry; 2005 Jun; 44(25):9140-9. PubMed ID: 15966738
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive study on the 5-hydroxytryptamine(3A) receptor binding of agonists serotonin and m-chlorophenylbiguanidine.
Hazai E; Joshi P; Skoviak EC; Suryanarayanan A; Schulte MK; Bikadi Z
Bioorg Med Chem; 2009 Aug; 17(16):5796-805. PubMed ID: 19640719
[TBL] [Abstract][Full Text] [Related]
3. Importance of recognition loops B and D in the activation of human 5-HT₃ receptors by 5-HT and meta-chlorophenylbiguanide.
Michaelson SD; Paulsen IM; Kozuska JL; Martin IL; Dunn SM
Neuropharmacology; 2013 Oct; 73():398-403. PubMed ID: 23810831
[TBL] [Abstract][Full Text] [Related]
4. General anesthetic-induced channel gating enhancement of 5-hydroxytryptamine type 3 receptors depends on receptor subunit composition.
Solt K; Stevens RJ; Davies PA; Raines DE
J Pharmacol Exp Ther; 2005 Nov; 315(2):771-6. PubMed ID: 16081679
[TBL] [Abstract][Full Text] [Related]
5. Molecular cloning and pharmacological characterization of serotonin 5-HT(3A) receptor subtype in dog.
Jensen TN; Nielsen J; Frederiksen K; Ebert B
Eur J Pharmacol; 2006 May; 538(1-3):23-31. PubMed ID: 16647053
[TBL] [Abstract][Full Text] [Related]
6. Importance of the C-terminus of the human 5-HT3A receptor subunit.
Butler AS; Lindesay SA; Dover TJ; Kennedy MD; Patchell VB; Levine BA; Hope AG; Barnes NM
Neuropharmacology; 2009 Jan; 56(1):292-302. PubMed ID: 18786552
[TBL] [Abstract][Full Text] [Related]
7. Different efficacy of specific agonists at 5-HT3 receptor splice variants: the role of the extra six amino acid segment.
Niemeyer MI; Lummis SC
Br J Pharmacol; 1998 Feb; 123(4):661-6. PubMed ID: 9517385
[TBL] [Abstract][Full Text] [Related]
8. Arginine 246 of the pretransmembrane domain 1 region alters 2,2,2-trichloroethanol action in the 5-hydroxytryptamine3A receptor.
Hu XQ; Peoples RW
J Pharmacol Exp Ther; 2008 Mar; 324(3):1011-8. PubMed ID: 18094321
[TBL] [Abstract][Full Text] [Related]
9. Isomerization of the proline in the M2-M3 linker is not required for activation of the human 5-HT3A receptor.
Paulsen IM; Martin IL; Dunn SM
J Neurochem; 2009 Aug; 110(3):870-8. PubMed ID: 19457066
[TBL] [Abstract][Full Text] [Related]
10. The role of residues in binding loop A in desflurane and propofol modulation of recombinant 5-HT3A receptor.
Koo BN; Kim MK; Yang J; Min KT
Neurosci Lett; 2009 Nov; 465(2):147-50. PubMed ID: 19765401
[TBL] [Abstract][Full Text] [Related]
11. Role of aspartate 298 in mouse 5-HT3A receptor gating and modulation by extracellular Ca2+.
Hu XQ; Lovinger DM
J Physiol; 2005 Oct; 568(Pt 2):381-96. PubMed ID: 16096341
[TBL] [Abstract][Full Text] [Related]
12. Mapping residues in the ligand-binding domain of the 5-HT(3) receptor onto d-tubocurarine structure.
Yan D; Meyer JK; White MM
Mol Pharmacol; 2006 Aug; 70(2):571-8. PubMed ID: 16723497
[TBL] [Abstract][Full Text] [Related]
13. Interactions of granisetron with an agonist-free 5-HT3A receptor model.
Joshi PR; Suryanarayanan A; Hazai E; Schulte MK; Maksay G; Bikádi Z
Biochemistry; 2006 Jan; 45(4):1099-105. PubMed ID: 16430206
[TBL] [Abstract][Full Text] [Related]
14. Computational analysis of ligand recognition sites of homo- and heteropentameric 5-HT3 receptors.
Moura Barbosa AJ; De Rienzo F; Ramos MJ; Menziani MC
Eur J Med Chem; 2010 Nov; 45(11):4746-60. PubMed ID: 20724042
[TBL] [Abstract][Full Text] [Related]
15. Importance of phenylalanine 107 in agonist recognition by the 5-hydroxytryptamine(3A) receptor.
Steward LJ; Boess FG; Steele JA; Liu D; Wong N; Martin IL
Mol Pharmacol; 2000 Jun; 57(6):1249-55. PubMed ID: 10825397
[TBL] [Abstract][Full Text] [Related]
16. Conformational Changes in the 5-HT
Munro L; Ladefoged LK; Padmanathan V; Andersen S; Schiøtt B; Kristensen AS
Mol Pharmacol; 2019 Dec; 96(6):720-734. PubMed ID: 31582575
[TBL] [Abstract][Full Text] [Related]
17. A triad of residues is functionally transferrable between 5-HT
Mosesso R; Dougherty DA
J Biol Chem; 2018 Feb; 293(8):2903-2914. PubMed ID: 29298898
[TBL] [Abstract][Full Text] [Related]
18. Spatial orientation of the antagonist granisetron in the ligand-binding site of the 5-HT3 receptor.
Yan D; White MM
Mol Pharmacol; 2005 Aug; 68(2):365-71. PubMed ID: 15914697
[TBL] [Abstract][Full Text] [Related]
19. Cis-trans isomerization at a proline opens the pore of a neurotransmitter-gated ion channel.
Lummis SC; Beene DL; Lee LW; Lester HA; Broadhurst RW; Dougherty DA
Nature; 2005 Nov; 438(7065):248-52. PubMed ID: 16281040
[TBL] [Abstract][Full Text] [Related]
20. N-terminal domains in mouse and human 5-hydroxytryptamine3A receptors confer partial agonist and antagonist properties to benzylidene analogs of anabaseine.
Zhang R; White NA; Soti FS; Kem WR; Machu TK
J Pharmacol Exp Ther; 2006 Jun; 317(3):1276-84. PubMed ID: 16551836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
